Amneal Pharmaceuticals
AMRX
AMRX
168 hedge funds and large institutions have $417M invested in Amneal Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 57 increasing their positions, 56 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
0.95% less ownership
Funds ownership: 67.46% → 66.51% (-0.95%)
13% less capital invested
Capital invested by funds: $480M → $417M (-$62.8M)
79% less call options, than puts
Call options by funds: $742K | Put options by funds: $3.57M
Holders
168
Holding in Top 10
1
Calls
$742K
Puts
$3.57M
Top Buyers
| 1 | +$5.24M | |
| 2 | +$1.1M | |
| 3 | +$1.03M | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$988K |
| 5 |
AG
Algert Global
San Francisco,
California
|
+$796K |
Top Sellers
| 1 | -$4.64M | |
| 2 | -$3.96M | |
| 3 | -$1.3M | |
| 4 |
Norges Bank
Oslo,
Norway
|
-$1.01M |
| 5 |
Goldman Sachs
New York
|
-$833K |